Kripton

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

Bromocriptine mesylate

Pieejams no:

Alphapharm Pty Ltd

Klase:

Medicine Registered

Lietošanas instrukcija

KRIPTON
1
KRIPTON
_contains the active ingredient bromocriptine (mesylate)_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Kripton.
It does not contain all the available
information.  It does not take the
place of talking to your doctor or
pharmacist.
All medicines have benefits and
risks.  Your doctor has weighed the
risks of you taking Kripton against
the benefits expected for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, TALK TO YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH YOUR
MEDICINE.
You may need to read it again.
WHAT KRIPTON IS USED
FOR
Kripton contains the active
ingredient bromocriptine which
belongs to a group of medicines
called ergot alkaloids.
Bromocriptine has an effect on the
body similar to that of a chemical
messenger occurring naturally in the
body called dopamine.
Kripton has several uses that have
been outlined below.
*
Prevention of breast milk
production (lactation) in women
who cannot breastfeed for
medical reasons. If breast milk
production has already begun,
your doctor can advise you about
other methods of stopping
lactation.
*
Treatment of abnormally high
blood levels of a hormone called
prolactin.  This condition is
sometimes caused by a tumour
called prolactinoma.  Kripton can
be used alone or in combination
with surgery to treat this tumour.
*
Treatment of acromegaly, a
disease in which the body
produces too much growth
hormone.  Kripton treats this
disease by reducing the excessive
amounts of growth hormone in
the blood.
*
Treatment of Parkinson's disease,
a condition where people
experience shaking (tremor),
muscle stiffness and slow and
unsteady body movements.
Kripton is often used in
combination with other
medicines such as levodopa to
treat Parkinson's disease.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY KRIPTON HAS
BEEN PRESCRIBED FOR YOU.
Your doctor may have prescribed
Kript

Produkta apraksts

KRIPTON 
_Bromocriptine (mesylate)_ 

PRODUCT INFORMATION 

NAME OF THE MEDICINE 

Active ingredient:  Bromocriptine mesylate. 

Chemical name:  Bromocriptine BAN is 2-bromo-
α-ergocryptine. 

Structural formula  
HN
Br
NMe
H
N
H
O
H
O
N
N
O
H
CH
2
CH
2
CHMe
2
O
OH
Pr
_i_
H
,CH
3
SO
3
H

Molecular formula:  C H BrN O CH O S 
he molecular weight of the free base is 654.5 and that of the mesylate
salt 750.6 
AS Registry No.:  22260-51-1 
ESCRIPTION 
a peptide ergot alkaloid, poorly soluble in water (<0.1% at 20-25
°C).  Solubility in 
thanol (70% v/v) is 75%. 
s:  lactose, starch-maize, silica-colloidal anhydrous, maleic acid,
disodium edetate and magnesium 
tearate. 
anium dioxide, iron oxide black, 
llura red AC, TekPrint SW-9008 Black Ink and TekPrint SW-9009 Black
Ink. 
HARMACOLOGY 
ronic administration.  However, it may suppress the elevated 
growth hormone levels of acromegalic patients. 
32
40
5
5
4
3

T

C

D

Bromocriptine mesylate is 
e

Kripton 2.5 tablets contains 2.5 mg of the active
ingredient bromocriptine mesylate and the following inactive 
ingredient
s

Kripton 5 and Kripton 10 capsules contain 5 mg and 10
mg, respectively, of the active ingredient bromocriptine 
mesylate.  The capsules also contain the following inactive
ingredients:  lactose, starch-maize, silica-colloidal 
anhydrous, maleic acid, magnesium stearate, sodium
lauryl sulfate, gelatin, tit
a

P

Bromocriptine has a pharmacological spectrum unlike that of most
classical ergot compounds, having no 
uterotonic and little vasoconstrictor activity.  Its principal
effects derive from dopaminergic receptor stimulant 
activity.  It inhibits prolactin secretion and the effect can be
demonstrated after single or repeated oral 
administration of the drug. 
Moreover, the effect is relatively specific in that doses necessary to produce inhibition 
of prolactin secretion do not interfere with release
of gonadotrophins or thy